Significant investment by pharmaceutical company Rontis in Larissa and Kozani
The Greek pharmaceutical company Rontis recently announced its new business plans during the handover ceremony of its new production and storage facilities in Larissa. The company aims to strengthen its presence in the Greek market through significant investments.
According to statements from management, Rontis is planning to expand its operations in Larissa, a move expected to boost the company's production capacity. The new facilities are modern and meet all the necessary specifications for the safe storage and production of pharmaceutical products.
Furthermore, the company set an ambitious goal for the future, announcing its intention to build a new factory in the region of Kozani. This project is expected to be completed by 2030, thereby contributing to the development of the local economy and the creation of new jobs.
These investments are part of a broader strategy by Rontis for the development of the healthcare sector in Greece. By expanding into two different regions, the company seeks to strengthen its role in the pharmaceutical industry while offering solutions that meet the needs of patients.